ORBIMED CAPITAL LLC

Overview

• HeadquartersAlbany, United States²
• Legal formLimited Liability Company²
• LEI5493005MDPTL643B8346²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 3168920²

See how the biggest companies compare on our leaderboards

Corporate structure

ORBIMED CAPITAL LLC sits at the top of its group. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.

Timeline

1. Feb 1, 2000Founded ORBIMED CAPITAL LLC is founded²

Filings

26 filings to the SEC since October 2021: 26 other. The latest 20:

1. Aug 28, 2026N-PX EDGAR
2. Aug 14, 202613F-NT EDGAR
3. May 15, 202613F-NT EDGAR
4. Feb 17, 202613F-NT EDGAR
5. Nov 14, 202513F-NT EDGAR
6. Aug 29, 2025N-PX EDGAR
7. Aug 14, 202513F-NT EDGAR
8. May 15, 202513F-NT EDGAR
9. Feb 14, 202513F-NT EDGAR
10. Nov 14, 202413F-NT EDGAR
11. Aug 29, 2024N-PX EDGAR
12. Aug 14, 202413F-NT EDGAR
13. May 15, 202413F-NT EDGAR
14. Feb 14, 202413F-NT EDGAR
15. Nov 14, 202313F-NT EDGAR
16. Aug 14, 202313F-NT EDGAR
17. Jun 15, 2023144 EDGAR
18. Jun 15, 2023144 EDGAR
19. May 15, 202313F-NT EDGAR
20. Mar 10, 2023144 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

ORBIMED CAPITAL LLC has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).

• SI-Bone (United States)SCHEDULE 13G/A Feb 11, 2022 to Feb 17, 2026³
• Helus Pharma Inc.SC 13G/A Feb 11, 2022 to Feb 14, 2023⁴
• Milestone Pharmaceuticals Inc.SC 13G/A Feb 11, 2022 to Feb 14, 2023⁵
• Aptose Biosciences Inc.SC 13G/A Feb 11, 2022⁶